Studies from Misericordia Hospital in the Area of Nuclear Medicine Described (Additional Diagnostic Value of Hybrid SPECT-CT Systems Imaging in Patients With Differentiated Thyroid Cancer)
By a News Reporter-Staff News Editor at Clinical Trials Week -- Current study results on Nuclear Medicine have been published. According to news reporting originating in Rovigo, Italy, by NewsRx journalists, research stated, "Nuclear medicine has entered a new era of multimodality imaging. Single-photon emission computed tomography/computed tomography (SPECT/CT) hybrid cameras are relatively new diagnostic tools that have been widely adopted and are present in most nuclear medicine units."
The news reporters obtained a quote from the research from Misericordia Hospital, "SPECT/CT instruments allow functional and morphologic images to be acquired as superimposed (fusion images) in a single session. The integration of CT enables better characterization of functional abnormalities identified on planar and SPECT scintigraphy by offering structural information. It thus highly improves accuracy compared with conventional scintigraphy. The combination of functional information and anatomic localization has the potential to influence medical practice with newer imaging algorithms."
According to the news reporters, the research concluded: "This review presents the current evidence and potential indications of SPECT/CT imaging in the initial staging, treatment, and follow-up of patients with differentiated thyroid cancer."
For more information on this research see: Additional Diagnostic Value of Hybrid SPECT-CT Systems Imaging in Patients With Differentiated Thyroid Cancer. American Journal of Clinical Oncology-Cancer Clinical Trials, 2014;37(3):305-313. American Journal of Clinical Oncology-Cancer Clinical Trials can be contacted at: Lippincott Williams & Wilkins, 530 Walnut St, Philadelphia, PA 19106-3621, USA (see also Nuclear Medicine).
Our news correspondents report that additional information may be obtained by contacting M.E. Toubert, Misericordia Hosp, Dept. of Nucl Med, Rovigo, Italy. Additional authors for this research include L. Vija, L. Vercellino, S. Banayan, I. Faugeron, N. Berenger, T. Meas, M.C. Marzola, S. Chondrogiannis, E. Hindie and D. Rubello.
Keywords for this news article include: Italy, Rovigo, Europe, Cancer, Oncology, Nuclear Medicine, Imaging Technology, Computed Tomography
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC